Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

United States Compounding Pharmacies Market: By Type: Oral, Topical, Suppositories, Others; By Compounding Type; By Sterility; By Therapeutic Area; By Distribution Channel; By Application; Historical Market and Forecast (2016-2026); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

United States Compounding Pharmacies Market Outlook

The United States compounding pharmacies market is being driven by the rising geriatric population and growing demand from parenteral division. The market is expected to grow at a CAGR of 6% in the forecast period of 2021-2026.

 

Rising Geriatric Population Boosting the Compounding Pharmacies Industry Growth

The rising geriatric demographic base, combined with increased longevity, are the primary drivers of market growth. According to the Population Reference Bureau, by 2060, the geriatric population of the United States is expected to account for about 24% of the total population. The population's longevity has risen as the birth rate has decreased and life expectancy has increased. Additionally, the industry's overall development is supported by compounding pharmacies' low costs over the forecast period. A higher percentage of consumers choose compounding pharmacies, as well as an increasing desire to look healthier and younger, has resulted in increased demand for anti-ageing drugs across the United States, consequently favouring the market growth.

 

United States Compounding Pharmacies Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Compounding Pharmacies:  Industry Definition and Segmentation

Compounding pharmacies refer to the on-demand distribution of computing resources over the internet, such as storage, servers, applications, and networking, to allow quicker innovation and economies of scale. Customers prefer compounding pharmacies over conventional on-premise deployments because it helps them to pay directly for the resources they need and handle their technology more effectively.

Based on type,  the market is divided into:

  • Oral
  • Topical
  • Suppositories
  • Others

With regards to compounding type, the market is segmented into:

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

On the basis of sterility, the market is bifurcated into:

  • Sterile
  • Non-sterile

By therapeutic area, the market is segregated into:

  • Pain and Management
  • Hormone Replacement Therapy (HRT)
  • Others

Based on distribution channel, the market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online 
  • Others

By application, the market is segmented into:

  • Pediatric
  • Adult
  • Geriatric
  • Veterinary
  • Others

 

Parenteral Division Fostering the Growth of United States Compounding Pharmacies Industry

The widespread acceptance of compounding pharmacies services, especially public cloud, is expected to boost the market growth of compounding pharmacies in the United States. In 2020, the parenteral division accounted for 18% of the market share of compounding pharmacies in the United States. Compounding ophthalmic treatment drugs, such as glaucoma medications, lower the cost, further boosting the adoption of the product. This has invigorated the market in recent years. Furthermore, compounded dose formulations such as glaucoma reductions assist elderly patients in reducing individual pressure as well as uncertainty about multiple drugs and dosing schedules, thus favouring retail value. Ophthalmic drugs may be administered in a variety of ways, including oral pills, capsules, injections, and drops. As a result, the increasing availability of multiple dosage types in ophthalmic treatment is expected to propel the segment forward. This is predicted to contribute to the overall market growth over the forecast period.

 

Key Industry Players in the United States Compounding Pharmacies Market

The report gives a detailed analysis of the following key players in the United States compounding pharmacies market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Fagron N.V.
  • PharMedium Services, LLC
  • Fresenius Kabi Canada
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Compounding Type, Sterility, Therapeutic Area, Distribution Channel, Application
Breakup by Type Oral, Topical, Suppositories, Others
Breakup by Compounding Type Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), Others
Breakup by Sterility Sterile, Non-sterile
Breakup by Therapeutic Area Pain Management, Hormone Replacement Therapy (HRT), Others
Breakup by Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online, Others
Breakup by Application Pediatric, Adult, Geriatric, Veterinary, Others
Market Dynamics SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand and Price
Competitive Landscape Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Fagron N.V., PharMedium Services, LLC, Fresenius Kabi Canada, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    United States
7    Industry Opportunities and Challenges
8    United States Compounding Pharmacies Market Analysis

    8.1    Key Industry Highlights
    8.2    United States Compounding Pharmacies Historical Market (2016-2020) 
    8.3    United States Compounding Pharmacies Market Forecast (2021-2026)
    8.4    United States Compounding Pharmacies Market by Type
        8.4.1    Oral
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Topical
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Suppositories
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Others
    8.5    United States Compounding Pharmacies Market by Compounding Type
        8.5.1    Pharmaceutical Ingredient Alteration (PIA)
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Currently Unavailable Pharmaceutical Manufacturing (CUPM)
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Pharmaceutical Dosage Alteration (PDA)
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Others
    8.6    United States Compounding Pharmacies Market by Sterility
        8.6.1    Sterile
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Non-sterile 
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
    8.7    United States Compounding Pharmacies Market by Therapeutic Area
        8.7.1    Pain Management
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Hormone Replacement Therapy (HRT)
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Others
    8.8    United States Compounding Pharmacies Market by Distribution Channel
        8.8.1    Hospital Pharmacies
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2016-2020)
            8.8.1.3    Forecast Trend (2021-2026)
        8.8.2    Retail Pharmacies
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2016-2020)
            8.8.2.3    Forecast Trend (2021-2026)
        8.8.3    Online
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2016-2020)
            8.8.3.3    Forecast Trend (2021-2026)
        8.8.4    Others
    8.9    United States Compounding Pharmacies Market by Application
        8.9.1    Pediatric
            8.9.1.1    Market Share
            8.9.1.2    Historical Trend (2016-2020)
            8.9.1.3    Forecast Trend (2021-2026)
        8.9.2    Adult
            8.9.2.1    Market Share
            8.9.2.2    Historical Trend (2016-2020)
            8.9.2.3    Forecast Trend (2021-2026)
        8.9.3    Geriatric 
            8.9.3.1    Market Share
            8.9.3.2    Historical Trend (2016-2020)
            8.9.3.3    Forecast Trend (2021-2026)
        8.9.4    Veterinary 
            8.9.4.1    Market Share
            8.9.4.2    Historical Trend (2016-2020)
            8.9.4.3    Forecast Trend (2021-2026)
        8.9.5    Others
9    Market Dynamics
    9.1    SWOT Analysis
        9.1.1    Strengths
        9.1.2    Weaknesses
        9.1.3    Opportunities
        9.1.4    Threats
    9.2    Porter’s Five Forces Analysis
        9.2.1    Supplier’s Power
        9.2.2    Buyer’s Power
        9.2.3    Threat of New Entrants
        9.2.4    Degree of Rivalry
        9.2.5    Threat of Substitutes
    9.3    EMR’s Key Indicators for Demand
    9.4    EMR’s Key Indicators for Price
10    Value Chain Analysis
11    Competitive Landscape

    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Fagron N.V.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    PharMedium Services, LLC
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Fresenius Kabi Canada
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Others
12    Industry Events and Developments


List of Figures and Tables

1.    United States Compounding Pharmacies Market: Key Industry Highlights, 2016 and 2026
2.    United States Compounding Pharmacies Historical Market: Breakup by Product (USD Billion), 2016-2020
3.    United States Compounding Pharmacies Market Forecast: Breakup by Product (USD Billion), 2021-2026
4.    United States Compounding Pharmacies Historical Market: Breakup by Compounding Type (USD Billion), 2016-2020
5.    United States Compounding Pharmacies Market Forecast: Breakup by Compounding Type (USD Billion), 2021-2026
6.    United States Compounding Pharmacies Historical Market: Breakup by Sterility (USD Billion), 2016-2020
7.    United States Compounding Pharmacies Market Forecast: Breakup by Sterility (USD Billion), 2021-2026
8.    United States Compounding Pharmacies Historical Market: Breakup by Therapeutic Area (USD Billion), 2016-2020
9.    United States Compounding Pharmacies Market Forecast: Breakup by Therapeutic Area (USD Billion), 2021-2026
10.    United States Compounding Pharmacies Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
11.    United States Compounding Pharmacies Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
12.    United States Compounding Pharmacies Historical Market: Breakup by Application (USD Billion), 2016-2020
13.    United States Compounding Pharmacies Market Forecast: Breakup by Application (USD Billion), 2021-2026
14.    United States Compounding Pharmacies Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER